News

The latest on managing care, value-based care, insurance markets, payers & providers

Patients like condensed drug information

Boiling down the complex and often dense (at least to laymen) medical information that’s distributed with prescriptions into one page of easily understood data seems to encourage patient engagement, according to a study by Catalina Health, a health care communications company. The study is the result of an improvement effort by Catalina and the Engelberg Center for Health Care Reform at the Brookings Institute.

Catalina distributed a patient medication information (PMI) form* in August 2012 to about 3,200 patients through Rite Aid stores in California and Michigan for three medications. It then polled by telephone to see how well the one-page format fared.

The form is part of a quality improvement effort by Catalina and the Engelberg Center for Health Care Reform at the Brookings Institute under an agreement with the FDA.

What respondents did with the written medication information

MC_1306_news_data_fig1D.pdf

How useful was the information?

MC_1306_news_data_fig1D.pdfMC_1306_news_data_fig1D.pdf

*The form was developed by a workgroup that includes Catalina, the Medical Cognition Laboratory at Duke University, Emory University School of Medicine, the Feinberg School of Medicine at Northwestern University, GlaxoSmithKline, Janssen, Pfizer, Purdue University College of Pharmacy and the Regenstrief Center for Healthcare Effectiveness Research.

Source: Patient Information Quality Improvement Survey Results, Catalina Health

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.